872714-81-3

Upstream product

• 872714-78-8 cis-tert-butyl 3-(aminomethyl)-4-hydroxypyrrolidine-1-carboxylate 
• 501-53-1 benzyl chloroformate 

Downstream Products

• 872717-45-8 1-N-Boc-cis-(3-(aminomethyl)-4-hydroxy)pyrrolidine 
• 1075260-05-7 phenylmethyl [((3S,4S)-1-{[(3R)-10-fluoro-5-oxo-2,3-dihydro-5H-[1,4]oxazino[2,3,4-ij]quinolin-3-yl]methyl}-4-hydroxy-3-pyrrolidinyl)methyl]carbamate 
• 1003945-22-9 phenylmethyl [((3S,4S)-4-hydroxy-1-{2-[7-(methyloxy)-2-oxo-1(2H)-quinolinyl]ethyl}-3-pyrrolidinyl)methyl]carbamate 
• 872716-81-9 phenylmethyl {[(3R,4S)-4-hydroxy-3-pyrrolidinyl]methyl}carbamate 

Relevant academic research and scientific papers

FUSED QUADRACYCLIC COMPOUNDS, COMPOSITIONS AND USES THEREOF

Provided herein are substituted fused quadracyclic compounds useful as inhibitors of MK2. The invention further provides pharmaceutical compositions of the compounds of the invention. The invention also provides medical uses of substituted fused quadracyclic compounds.

ANTIBACTERIAL AGENTS

Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.